Geode Capital Management’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Geode Capital Management’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-816,989	Closed	-$81K	–	4114
2016 Q3	$81K	Hold	816,989	–	–	﹤0.01%	3850
2016 Q2	$302K	Hold	816,989	–	–	﹤0.01%	3430
2016 Q1	$308K	Hold	816,989	–	–	﹤0.01%	3459
2015 Q4	$318K	Hold	816,989	–	–	﹤0.01%	3481
2015 Q3	$469K	Buy	+816,989	New	+$419K	﹤0.01%	3246

Other funds holding PVCT

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Home Federal Bank of Tennessee Knoxville, Tennessee $465M AUM 18.18% 1-Year Est. Return

Geode Capital Management's PVCT Position: Q4 2016 in Review

Geode Capital Management sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 816,989 shares — an estimated $81K sold.

Geode Capital Management first reported a position in PVCT in Q3 2015 and held it in 5 quarters. The position peaked at $469K in Q3 2015. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Geode Capital Management reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Geode Capital Management sold 816,989 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $81K.
Geode Capital Management first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q3 2015 and held it in 5 quarters.
Geode Capital Management's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $469K in Q3 2015.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Geode Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.